Diligent Pharma
Patricia Leuchten is a seasoned professional in the Life Sciences industry, currently serving as the Founder and CEO of Diligent Pharma since June 2018, where the Diligent Qualification Platform transforms vendor qualification for clinical trials. Prior to this role, Patricia founded and led WCG Avoca and served as Chief Change Officer at WCG from April 2021 to July 2022. Patricia's extensive experience includes founding The Avoca Group in 1999, focusing on improving quality and compliance in clinical trial execution, as well as forming the Avoca Quality Consortium in 2012. Earlier career positions include Senior Director roles in business development and marketing at The Covalent Group, data management and biostatistics at PPD, and business development at Pharmaco LSR. Patricia holds a Bachelor's Degree in Molecular Biology from Lehigh University.
This person is not in any teams
Diligent Pharma
Diligent Pharma is a Quality and Risk Management Organization with a central platform for driving speed, efficiency, and high compliance in clinical trial vendor qualification. We are the clinical trial industry’s leading vendor qualification ecosystem, connecting pharma and biotech sponsors to a global network of Diligent Qualified GCP and GCLP providers. Diligent’s central platform and comprehensive, rigorous solutions drive high quality and compliance, expedite vendor qualification, mitigate risks and reduce costs, helping clinical trials get off the ground faster and with confidence.